B7 family molecules: Novel immunomodulators at the maternal-fetal interface

Placenta

Volumn 23, Issue SUPPL. 1, 2002, Pages

  Petroff, M G ^a   Chen, L ^b   Phillips, T A ^a   Hunt, J S ^a  

^a UNIVERSITY OF KANSAS SCHOOL OF MEDICINE   (United States)

^b MAYO CLINIC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

B LYMPHOCYTE RECEPTOR; B7 ANTIGEN; CD86 ANTIGEN; GAMMA INTERFERON; PROTEIN DERIVATIVE; CD274 PROTEIN, HUMAN; IMMUNOLOGICAL ADJUVANT; LEUKOCYTE ANTIGEN; MEMBRANE PROTEIN; MESSENGER RNA; PEPTIDE; PLASMA PROTEIN; RECOMBINANT GAMMA INTERFERON;

BINDING AFFINITY; CELL PROLIFERATION; CORRELATION ANALYSIS; FIRST TRIMESTER PREGNANCY; GENE CONTROL; GENETIC TRANSCRIPTION; HUMAN; IMMUNOHISTOLOGY; IMMUNOMODULATION; LEUKOCYTE; MOLECULAR MECHANICS; MOTHER FETUS RELATIONSHIP; NONHUMAN; PLACENTA DEVELOPMENT; PRIORITY JOURNAL; PROTEIN FAMILY; REVIEW; SEQUENCE HOMOLOGY; SIGNAL TRANSDUCTION; SYNCYTIOTROPHOBLAST; T LYMPHOCYTE ACTIVATION; ADULT; CELL CULTURE; CHORIOCARCINOMA; DISEASE MODEL; DNA RESPONSIVE ELEMENT; DOSE RESPONSE; DRUG EFFECT; FEMALE; FETOMATERNAL TRANSFUSION; GENETICS; GESTATIONAL AGE; IMMUNOLOGY; METABOLISM; PHYSIOLOGY; PREGNANCY; TROPHOBLAST;

ADJUVANTS, IMMUNOLOGIC; ADULT; ANTIGENS, CD; ANTIGENS, CD80; BLOOD PROTEINS; CHORIOCARCINOMA; DISEASE MODELS, ANIMAL; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GESTATIONAL AGE; HUMANS; INTERFERON-GAMMA, RECOMBINANT; MATERNAL-FETAL EXCHANGE; MEMBRANE GLYCOPROTEINS; PEPTIDES; PREGNANCY; RESPONSE ELEMENTS; RNA, MESSENGER; TROPHOBLASTS; TUMOR CELLS, CULTURED;

EID: 3142728923     PISSN: 01434004     EISSN: None     Source Type: Journal    
DOI: 10.1053/plac.2002.0813     Document Type: Article

References (35)

1. Bulmer JN, Morrison L, Johnson PM & Meager A (1990) Immunohistochemical localization of interferons in human placental tissues in normal, ectopic, and molar pregnancy. Am J Reprod Immunol 22, 109-116.
2. Chambers CA, Kuhns MS, Egen JG & Allison JP (2001) CTLA-4-mediated inhibition in regulation of T cell responses: mechanisms and manipulation in tumor immunotherapy. Annu Rev Immunol, 19> 565-594.
3. Chapoval Al, Ni J, Lau JS, Wilcox RA, Flies DB, Liu D, Dong H, Sica GL, Zhu G, Tamada K & dien L (2001) B7-H3: a costimulatory molecule for T cell activation and IFN-gamma production. Nat Immunol, 2, 269-274.
4. Dong H, Zhu G, Tamada K & Chen L (1999) B7-H1, a third member of the B7 family, co-stimulates T-cell proliferation and interleukin-10 secretion. Nat Med, 5., 1365-1369.
5. Dong C, Juedes AE, Temann U, Shresta S, Allison JP, Ruddle NH & Flavell RA (2001) ICOS co-stimulatory receptor is essential for T-cell activation and function. Nature., 409, 97-101.
6. Freeman GJ, Long AJ, Iwai Y, Bourque K, Chernova T, Nishimura H, Fitz LJ, Malenkovich N, Okazaki T, Byrne MC, Horton HF, Fouser L, Carter L, Ling V, Bowman MR, Carreno BM, Collins M, Wood CR & Honjo T (2000) Engagement of the PD-1 immuno inhibitory receptor by a novel B7 family member leads to negative regulation of lymphocyte activation. J Exp Med, 192, 1027-1034.
7. Freeman GJ, Boussiotis VA, Anumanthan A, Bernstein GM, Ke XY, Rennert PD, Gray GS, Gribben JG & Nadler LM (1995) B7-1 and B7-2 do not deliver identical costimulatory signals, since B7-2 but not B7-1 preferentially ccutiumulates the initial production of IL-4. Immunity, 2, 523-532.
8. Harris NL & Ronchese F (1999) The role of B7 costimulation in T-cell immunity. Immunol Cell Biol, 77, 304-311.
9. Hunt JS, Miller L, Roby KF, Huang J, Platt & DeBrot BL (1997) Female steroid hormones regulate production of pro-inflammatory molecules in uterine leukocytes. J Reprod Immunol, 35, 87-99.
10. Hutter H, Hammer A, Dohr G & Hunt JS (199S) HLA expression at the maternal-fetal interface. Dev Immunol, 6, 197-204.
11. Ishida Y, Agata Y, Shibahara K & Honjo T (1992) Induced expression of PD-1, a novel member of the immunoglobulin gene superfamily, upon programmed cell death. EMBOJ, 11, 3887-3895.
12. Kapasi K, Albert SE, Yie S, Zavazava N & Librach CL (2000) HLA-G has a concentration-de pendent effect on the generation of an allo-GTL response. Immunology, 101, 191-200.
13. Kelly RW, Carr GG, Elliott CL, Tulppala M & Critchley HOD (1995) Prostaglandin and cytokine release by trophoblastic villi. Hum Reprod, 10, 3289-3292.
14. King A, Hiby SE, Gardner L, Joseph S, Bowen JM, Verma S, Burrows D & Loke YW (2000) Recognition of trop hoblast HLA class I molecules by decidual NK cell receptors-a review. Placenta, 21, S81-S85.
15. Latchman Y, Wood CR, Chernova T, Chaudhary D, Borde M, Chernova I, Iwai Y, Long AJ, Brown JA, Nunes R, Greenfteld EA, Bourque K, Boussiotis VA, Carter LL, Carreno BM, Malenkovich N, Nishimura H, Okazaki T, Honjo T, Sharpe AH & Freeman GJ (2001) PD-L2 is a second ligand for PD-I and inhibits T cell activation. Nat Immunol, 2, 261-268.
16. Le Gal FA, Riteau B, Selik C, Kaher I, Nenier C, Dausset J, Guillet JG, Carosella ED & Rouas Freiss N (1999) HLA-G-mediated inhibition of antigen-specific cytotoxic T lymphocytes. Int Immunol, 11, 1351-1356.
17. Lenschow DJ, Ho SC, Sattar H, Rhee L, Gray G, Nabavi N, Herold KC & Bluestone JA (1995) Differential effects of anti B7-1 and anti-B7-2 monoclonal antibody treatment on the development of diabetes in the nonobese diabetic mouse. J Exp Med, 181, 1145-1155.
18. Marzi M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici E & Clerici M (1996) Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol, 106, 127-133.
19. Matzinger P (1994) Tolerance, danger, and the extended family. Anna Rev Immunol, 12, 991-1045.
20. Nishimura H, Nose M, Hiai H, Minato N & Honjo T (1999) Development of lupus-like autoimmune diseases by disruption of the PD-1 gene encoding an ITIM motif-carry in g immunoreceptor. Immunity, 11, 141-151.
21. Nishimura H, Okazaki T, Tanaka Y, Nakatani K, Hara M, Matsuinori A, Sasayama S, Mizoguchi A, Hiai H, Minato N & Honjo T (2001) Autoimmune dilated cardiomyopathy in PD-1 receptor-deficient mice. Science, 291, 319-322.
22. Nishimura H & Honjo T (2001) PD-1: and inhibitory immunoreceptor involved in peripheral tolerance. Trends Immunol, 22, 265-268.
23. Okazalii T, Maeda A, Nishimura H, Kurosaki T & Honjo T (2001) PD-1 immunoreceptor inhibits B cell receptor-mediated signaling by recruiting src homology 2-domain-containing tyrosine phosphatase 2 to phosphotyrosine. Proc Natl Acad Sci USA, 98, 13866-13871.
24. 2-mediated immunosuppression by first trimester human decidual cells blocks activation of maternal leukocytes in the decidua with potential anti-trophoblast activity. Cellular Immunol, 120, 61-74.
25. Phillips TA, Ni J, Pan S, Ruben SM, Wei YF, Pace JL & Hunt JS (1999) TRAIL (Apc-2L) and TRAIL receptors in human placentas: implications for immune privilege. J Immunol, 162, 6053-6059.
26. Piccinni MP, Beloni L, Livi C, Maggi E, Scarselli G & Romagnani S (1995) Defective production of both leukemia inhibitory factor and type 2 T-helper cytokines by decidual T cells in unexplained recurrent abortions. Nature Med, 9, 1020-1024.
27. Platt JS & Hunt JS (199S) Interferon-γ gene expression in cycling and pregnant mouse uterus: temporal aspects and cellular localization. J Leuk Biol, 64, 393-400.
28. Roth I, Corry DB, Locksley RM, Abrams JS, Litton MJ & Fisher SJ (1996) Human placental cytotrophoblasts produce the immunosuppressive cytokine interleukin 10. Exp Med, 184, 539-548.
29. Scharenberg AM & Kinet J-P (1996) The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP? Cell, 87, 961-964.
30. Shinohara T, Taniwaki M, Ishida Y, Kawaichi M & Honjo T (1994) Structure and chromosomal localization of the human PD-1 gene (PDGD1). Genomics, 23, 704-706.
31. Shlapatska LM, Mikhalap SV, Berdova AG, Zelensky OM, Yun TJ, Nichols KE, Clark EA & Sidorenko SP (2001) GD150 association with either the SH2-containing inositol phosphatase or the SH2-containing protein tyrosine phcsphatase is regulated by the adaptor protein SH2D1A. J Immunol, 166, 5480-5487.
32. Sperling AI & Bluestone JA (2001) IGOS cosstimulation: it's not just for Th2 cells anymore. Nature Immunol, 2, 573-574.
33. Tafuri A, Shahinian A, Bladt F, Yoshinaga SK, Jordana M, Wakeham A, Boucher L, Bouchard D, Chan VSF, Duncan G, Oderrnatt B, Ho A, Itie A, Horan T, Whoriskey JS, Pawson T, Penninger JM, Ohashi PS & Mak TW (2001) ICOS is essential for effective T-helper-cell responses. Nature, 401, 105-109.
34. Tarnura H, Dong H, Zhu G, Sica GL, Flies DB, Taniada K & Chen L (2001) B7-H1 costimulation preferentially enhances GD 28-independent T-helper cell function. Blood, 97, 1809-1816.
35. Tseng SY, Otsuji M, Gorski K, Huang X, Slansky JE, Pai SI, Shalabi A, Shin T, Pardoll DM & Tsuchiya H (2001) B7-DG, a new dendritic cell molecule with potent costimulatory properties for T cells. J Exp Med, 193, 839-846.